Department of Medicine, Division of Preventive Medicine, University of Alabama at Birmingham, 1717 11th Avenue South, Birmingham, AL 35205, USA.
Department of Epidemiology and Biostatistics, School of Public Health, Indiana University-Bloomington, 1025 E. 7th Street, Bloomington, IN 47405, USA.
Contemp Clin Trials. 2021 Aug;107:106463. doi: 10.1016/j.cct.2021.106463. Epub 2021 May 31.
Background Daily self-weighing (DSW) may be an effective harm-reduction intervention to disrupt continued weight gain. Self-Weighing for Obesity Management in Primary Care (SWOP) is a 24-month randomized controlled trial in 400 adults with obesity (BMI: kg/m ≥ 30) receiving primary care through a clinical network affiliated with an academic medical center. Objective To test DSW as a potentially scalable way to deter age-related weight gain among primary care patients with obesity. Methods Randomized-controlled trial with two conditions: DSW (instruction to weigh daily and provision of a web-enabled digital scale with graphical weight feedback) or Standard Care (receive a monetary gift card equivalent to value of the scale). Both groups receive standardized weight management educational material. SWOP will test the causal effect of assignment to DSW (Aim 1) and adherence to DSW (Aim 2) on weight (primary outcome) and adoption of weight management practices (secondary outcomes), as well as evaluate the cost-effectiveness of DSW compared to standard care (Aim 3). Findings may inform clinical guidelines for weight management by providing evidence that DSW attenuates continued age-related weight gain among adults with obesity. This trial is registered with ClinicalTrials.gov (NCT04044794).
每日自我称重（DSW）可能是一种有效的减少伤害的干预措施，可以阻止持续的体重增加。“初级保健中用于肥胖管理的自我称重（SWOP）”是一项为期 24 个月的随机对照试验，涉及 400 名通过隶属于学术医疗中心的临床网络接受初级保健的肥胖成年人（BMI：kg/m≥30）。目的：测试 DSW 是否可以作为一种潜在的可扩展方法，阻止初级保健肥胖患者的年龄相关体重增加。方法：采用随机对照试验，分为两组：DSW（每日称重的指导和提供带有图形体重反馈的网络启用数字秤）或标准护理（获得相当于秤价值的货币礼品卡）。两组均接受标准化的体重管理教育材料。SWOP 将测试分配给 DSW（目标 1）和遵守 DSW（目标 2）对体重（主要结果）和体重管理实践的采用（次要结果）的因果效应，同时评估与标准护理相比，DSW 的成本效益（目标 3）。研究结果可能会为体重管理的临床指南提供信息，为 DSW 减轻肥胖成年人持续的年龄相关体重增加提供证据。该试验已在 ClinicalTrials.gov 注册（NCT04044794）。
